Stay updated on PF-06463922 ALK/ROS1 Inhibitor Clinical Trial

Sign up to get notified when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The revision tag changed from v3.5.3 to v3.5.4, indicating a new release version. This update records the deployment change and does not alter the page’s substantive content or data.
    Difference
    0.0%
    Check dated 2026-05-17T10:01:18.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Updated the ClinicalTrials.gov page build/version indicator from “Revision: v3.5.2” to “Revision: v3.5.3.” This reflects a site update rather than a change to the underlying trial record history.
    Difference
    0.0%
    Check dated 2026-04-25T18:44:12.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added revision label v3.5.2 to the history and removed the v3.5.0 entry.
    Difference
    0.0%
    Check dated 2026-04-18T13:35:53.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 to the page history. Removed Revision: v3.4.3 from the history.
    Difference
    0.0%
    Check dated 2026-03-21T00:44:49.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Added revision: v3.4.3 and removed revision: v3.4.2 from the Record History.
    Difference
    0.0%
    Check dated 2026-03-06T18:36:24.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    New revision added: v3.4.2, replacing v3.4.1 in the history. No substantive page content changes are evident.
    Difference
    0.0%
    Check dated 2026-02-13T12:36:55.000Z thumbnail image

Stay in the know with updates to PF-06463922 ALK/ROS1 Inhibitor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.